Pharmaceutical Manufacturing Equipment Industry

The report "Pharmaceutical Manufacturing Equipment Market by Machine (Mixing & Blending, Milling, Spray Drying, Granulation, Extrusion, Tablet Compression, Sterilization, and Inspection), Process (Encapsulation, Formulation, Aseptic) - Global Forecast to 2029" The global pharmaceutical manufacturing equipment market size is projected to grow from USD 19.41 billion in 2024 to USD 26.94 billion in 2029, recording a CAGR of 6.8% during the forecast period.

Browse 236 market data Tables and 51 Figures spread through 246 Pages and in-depth TOC on "Pharmaceutical Manufacturing Equipment Market"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-manufacturing-equipment-market-268102519.html

The pharmaceutical manufacturing equipment market is growing rapidly as the demand for pharmaceuticals, especially generic drugs, is on the rise. Generic drugs offer a more affordable alternative to branded medications and have therefore been an important solution for these needs. The investment on advanced equipment and technology has taken place in manufacturing in pharmaceuticals companies to help smoothen the production process by increasing efficiency.

Mixing & blending machines segment is estimated to have the second largest market in the pharmaceutical manufacturing equipment market in 2023.

The mixing and blending machines held the second greatest market share for pharmaceutical equipment manufacturing due to the guarantees of consistency, quality, significant reduction of mixing time, and an array of viscosities that is possible. Their versatility allows for effective emulsifying, homogenizing and particle size reduction for making drugs more efficacious. Also, these devices have designs to meet rigid regulations with the ability to allow for cleaning and easy maintenance that can be met through FDA and cGMP requirements. Its cost effectiveness will also be enhanced through saving on energy and improving process efficiencies as advancements in digital technology provide improvement in monitoring and control.

Solid segment is expected to hold major share in the pharmaceutical manufacturing equipment market in 2023.

Solid dosage forms remain the most widely prescribed worldwide and continue to be the demand driver for efficient production equipment. With the rising prevalence of chronic diseases, the trend has further been influenced by the need for convenience and accuracy in dosing, thereby driving a higher demand for quality solid dosage manufacturing. Furthermore, innovations in solid dosage technology regarding better automation, precision, and scalability have increased capabilities for production, thus it becomes a first choice among pharmaceutical companies.

Europe is expected to witness the second highest CAGR of the pharmaceutical manufacturing equipment market during forecast period.

The growing demand for pharmaceuticals in Europe is driven by the changing healthcare requirements and the growing incidence of chronic diseases, which impose a high demand on the need for efficient production and packaging solutions. Such a surge in demand requires more advanced manufacturing equipment that would ensure quality and comply with the stringent regulations of organizations such as the European Medicines Agency (EMA). Further, European pharmaceutical companies increasingly have embraced flexible manufacturing practices to help them make a diverse set of formulations of drugs with ease such as oral, parenteral, and topical. The flexibility allows them to adjust in response to the changes happening very fast in the marketplace.

The key companies in the pharmaceutical manufacturing equipment market include GEA Group Aktiengesellschaft (Germany), I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A. (Italy), Syntegon Technology GmbH (Germany), Romaco Group (Germany), ACG (India), Körber AG (Germany), Thermo Fisher Scientific Inc. (US), Marchesini Group (Italy), MG2 s.r.l (Italy), Glatt GmbH (Germany).

Don’t miss out on business opportunities in Pharmaceutical Manufacturing Equipment Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]